Targeted Strategies for Today's Evolving Markets

MissionIR Blog

BioRestorative Therapies, Inc. (BRTX) Starts Presentation at 2015 Marcum MicroCap Conference

BioRestorative Therapies develops products and medical therapies using cell and tissue protocols, primarily involving adult stem cells. The company’s lead cell therapy candidate, brtxDISC, is formulated from autologous (or a person’s own) cultured mesenchymal stem cells collected from the patient’s bone marrow intend for use in the non-surgical treatment of protruding and bulging lumbar discs in patients suffering from chronic lumbar disc disease. The company is also developing an allogeneic cell-based therapy to target obesity and metabolic disorders. For more information, visit the company’s website at

The Marcum MicroCap Conference is a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The two-day 2016 conference will include feature presentations by CEOs and CFOs from seven principal industry sectors, expert panels moderated by industry leaders, and the opportunity to meet with management of presenting companies on a one-on-one basis. Marcum is partnered with KCSA Strategic Communications to present this year's Marcum MicroCap Conference.
This entry was posted in Marcum MicroCap. Bookmark the permalink.

Comments are closed.